NLS Pharmaceutics Ltd. Gains 38.46%
NLS Pharmaceutics Ltd. (NLSP:NASDAQ) rocketted at $0.72, a gain of 38.5%. On Wed, Nov 23, 2022, NLSP:NASDAQ touched a New 2-Week High of $0.72. The stock got featured on our News Catalysts scanner on Wed, Nov 23, 2022 at 08:58 AM in the 'MISCELLANEOUS' category. From Wed, Nov 09, 2022, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Nov 01, 2022 at $0.93 with a volume of 17M+.
About NLS Pharmaceutics Ltd. (NLSP:NASDAQ)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders.
Top 10 Gainers:
- Kalera Public Limited Company (KAL:NASDAQ), 76.92%
- Venus Concept Inc. (VERO:NASDAQ), 59.96%
- Porch Group Inc. (PRCH:NASDAQ), 40.94%
- Perfect Corp. Class A (PERF:NYSE), 39.28%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 38.46%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 35.83%
- TeraWulf Inc. (WULF:NASDAQ), 33.59%
- Exagen Inc. (XGN:NASDAQ), 32.81%
- The Very Good Food Company Inc. (VGFC:NASDAQ), 31.92%
- XL Group Ltd (XL:NYSE), 30.91%